2. Ramachandran S, French JM, Vanderpump MPJ, Croft P, Neary RH. Using the Framinghammodel to predict heart disease in the United Kingdom: retrospective study. BMJ 2000;320:676-677

3. Forge BH, Briganti EM. Lipid lowering and coronary heart disease risk: how appropriate are the national guidelines?. Med J Aust 2001; 175(9):471-5

4. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Cjte R, Grover SA, Fortin PR, Clarke AE, Senecal JL. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001 Oct;44(10):2331-7

5. Allen J. Taylor, Allen P. Burke, Patrick G. OMalley, Andrew Farb, Gray T. Malcom, John Smialek, Renu Virmani. A Comparison of the FraminghamRisk Index, Coronary Artery Calcification, and Culprit Plaque Morphology in Sudden Cardiac Death. Circulation 2000;101:1243.

6. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 1992 Sep 15;70(7):733-7

7. Assmann G, Cullen P, Schulte H. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Munster (PROCAM) Study.
Autor: FUNDACION SANTAFE DE BOGOTA
 
<< Pgina Anterior           Pgina Siguiente >> 

[Pgina 1]    [Pgina 2]    [Pgina 3]    [Pgina 4]    [Pgina 5]    [Pgina 6]    
[Pgina 7]    [Pgina 8]    [Pgina 9]    [Pgina 10]